74- year-old man with LRMDS and Transfusion Dependent Anemia
Video Player is loading.
Clinical Presentation: 74-year-old man diagnosed 1 years ago with LR-MDS with moderate anemia (Hb 11.2 g/dL) Non-del(5q)
• No family history of cancer or significant genotoxic agent exposure
• Serum EPO - 250m U/L, Ring sideroblast (RS) positive • IPSS-R: Low
• Received 2 units of blood every 2 months for 4 months; at that point they started therapy with ESAs.
• At 12 weeks, Hb remained essentially the same (11.4 g/dL) and transfusion needs decreased.
• At 20 weeks, his Hb is now 10.8 g/dL and he now is requiring 2-3 units of blood every month.
Recent Videos
Ruxolitinib Therapy for cGVHD: Insights on Patient and Safety Monitoring
Personalized JAK Inhibitor Selection in Myelofibrosis: Clinical Characteristics, Molecular Profiles, and Treatment Sequencing
Advancing Treatment Paradigms in Myeloproliferative Neoplasms: From Molecular Pathogenesis to Patient-Tailored Therapy
Diagnostic Challenges in Myelofibrosis: Distinguishing Prefibrotic Disease_
The Evolving Landscape of Myelofibrosis: Current Understanding and Clinical Patterns
Insights from COCOON: Prophylactic Dermatologic Management With Amivantamab + Lazertinib in Advanced NSCLC
1L Treatment for Advanced NSCLC
Recap: ELCC 2025 Highlights
Presented at ELCC 2025: Key Takeaways From KRYSTAL-7
ELCC 2025: Insights From the MARIPOSA Study
Related Content
